tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ACXP Stock Latest News

Acurx Pharmaceuticals’ Earnings Call: Progress Amidst Funding Challenges
Company AnnouncementsAcurx Pharmaceuticals’ Earnings Call: Progress Amidst Funding Challenges
5d ago
ACXP
Acurx assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Acurx assumed with a Buy at H.C. Wainwright
5d ago
ACXP
Acurx Pharmaceuticals: Promising Antibiotic Developments and Strong Financial Position Justify Buy Rating
PremiumRatings
Acurx Pharmaceuticals: Promising Antibiotic Developments and Strong Financial Position Justify Buy Rating
6d ago
ACXP
Acurx Pharmaceuticals Reports Improved Q1 2025 Results
PremiumCompany Announcements
Acurx Pharmaceuticals Reports Improved Q1 2025 Results
6d ago
ACXP
Acurx Pharmaceuticals Enters $12M Stock Purchase Agreement
PremiumCompany Announcements
Acurx Pharmaceuticals Enters $12M Stock Purchase Agreement
12d ago
8K
ACXP
Acurx granted new patent for DNA Polymerase IIIC Inhibitors
PremiumThe FlyAcurx granted new patent for DNA Polymerase IIIC Inhibitors
1M ago
ACXP
Acurx files to sell 8.4M shares of common stock for holders
Premium
The Fly
Acurx files to sell 8.4M shares of common stock for holders
2M ago
ACXP
Optimistic Buy Rating for Acurx Pharmaceuticals Amidst Financial Challenges and Promising Ibezapolstat Data
Premium
Ratings
Optimistic Buy Rating for Acurx Pharmaceuticals Amidst Financial Challenges and Promising Ibezapolstat Data
2M ago
ACXP
Strategic Phase 3 Trials and Unique Microbiome Effects Drive Buy Rating for Acurx Pharmaceuticals
PremiumRatings
Strategic Phase 3 Trials and Unique Microbiome Effects Drive Buy Rating for Acurx Pharmaceuticals
2M ago
ACXP
Acurx Pharmaceuticals Reports 2024 Results and Advances Trials
PremiumCompany Announcements
Acurx Pharmaceuticals Reports 2024 Results and Advances Trials
2M ago
ACXP
Acurx Pharmaceuticals’ Optimistic Earnings Call Highlights Clinical Progress
PremiumCompany Announcements
Acurx Pharmaceuticals’ Optimistic Earnings Call Highlights Clinical Progress
2M ago
ACXP
Acurx price target lowered to $5 from $14 at Alliance Global Partners
PremiumThe Fly
Acurx price target lowered to $5 from $14 at Alliance Global Partners
2M ago
ACXP
Acurx reports Q4 EPS (16c) vs. (37c) last year
PremiumThe FlyAcurx reports Q4 EPS (16c) vs. (37c) last year
2M ago
ACXP
Acurx to sell 2.745M shares at 40c in registered direct offering
Premium
The Fly
Acurx to sell 2.745M shares at 40c in registered direct offering
2M ago
ACXP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ACXP
ALLR
Acurx’s ibezapolstat shows efficacy in CDI treatment
PremiumThe Fly
Acurx’s ibezapolstat shows efficacy in CDI treatment
3M ago
ACXP
Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors
PremiumThe Fly
Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors
3M ago
ACXP
Acurx files to sell 2.61M shares of common stock for holders
PremiumThe Fly
Acurx files to sell 2.61M shares of common stock for holders
4M ago
ACXP
Acurx to sell 2.46M shares at $1.015 in registered direct offering
PremiumThe Fly
Acurx to sell 2.46M shares at $1.015 in registered direct offering
4M ago
ACXP
Acurx receives positive EMA guidance for ibezapolstat Phase 3 program
PremiumThe FlyAcurx receives positive EMA guidance for ibezapolstat Phase 3 program
4M ago
ACXP
Acurx updates Phase 3 readiness for ibezapolstat in C. difficile Infection
Premium
The Fly
Acurx updates Phase 3 readiness for ibezapolstat in C. difficile Infection
5M ago
ACXP
Acurx board approves Bitcoin as treasury reserve asset
Premium
The Fly
Acurx board approves Bitcoin as treasury reserve asset
6M ago
ACXP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >